Your browser is no longer supported. Please, upgrade your browser.
BCR C. R. Bard, Inc. monthly Stock Chart
BCR [NYSE]
C. R. Bard, Inc.
IndexS&P 500 P/E35.55 EPS (ttm)7.03 Insider Own0.50% Shs Outstand72.31M Perf Week-0.37%
Market Cap18.07B Forward P/E19.42 EPS next Y12.87 Insider Trans-52.63% Shs Float72.16M Perf Month2.53%
Income528.80M PEG3.13 EPS next Q2.65 Inst Own91.10% Short Float1.87% Perf Quarter13.90%
Sales3.71B P/S4.87 EPS this Y297.20% Inst Trans-0.62% Short Ratio2.37 Perf Half Y8.27%
Book/sh22.64 P/B11.04 EPS next Y10.51% ROA10.00% Target Price249.47 Perf Year26.66%
Cash/sh12.52 P/C19.97 EPS next 5Y11.35% ROE32.60% 52W Range195.48 - 252.25 Perf YTD11.36%
Dividend1.04 P/FCF48.74 EPS past 5Y13.80% ROI17.30% 52W High-0.93% Beta0.63
Dividend %0.42% Quick Ratio1.70 Sales past 5Y5.10% Gross Margin63.10% 52W Low27.84% ATR2.63
Employees16300 Current Ratio2.10 Sales Q/Q11.10% Oper. Margin19.20% RSI (14)63.33 Volatility1.07% 1.04%
OptionableYes Debt/Eq0.98 EPS Q/Q-18.10% Profit Margin14.20% Rel Volume0.77 Prev Close248.73
ShortableYes LT Debt/Eq0.98 EarningsApr 27 AMC Payout14.00% Avg Volume568.76K Price249.91
Recom2.40 SMA200.74% SMA503.52% SMA20010.24% Volume435,866 Change0.47%
Jan-05-17Upgrade Raymond James Outperform → Strong Buy $265
Jan-03-17Upgrade Morgan Stanley Equal-Weight → Overweight $240 → $260
Sep-16-16Upgrade Wells Fargo Market Perform → Outperform
Jul-27-16Reiterated Deutsche Bank Hold $234 → $240
Jul-27-16Reiterated Barclays Equal Weight $224 → $235
Jul-08-16Downgrade BofA/Merrill Buy → Neutral
May-24-16Reiterated Barclays Equal Weight $212 → $224
Apr-28-16Reiterated Barclays Equal Weight $195 → $212
Mar-17-16Initiated Nomura Neutral
Nov-12-15Initiated Citigroup Buy
Aug-27-15Upgrade Goldman Neutral → Buy
Apr-24-15Reiterated Barclays Equal Weight $175 → $185
Jan-30-15Reiterated Barclays Equal Weight $150 → $175
Jun-18-14Downgrade Barclays Overweight → Equal Weight $155 → $150
Mar-06-14Reiterated Barclays Overweight $150 → $160
Jan-09-14Reiterated Barclays Overweight $140 → $150
Oct-23-13Reiterated Barclays Overweight $135 → $140
Sep-04-13Initiated Needham Hold
Jul-24-13Reiterated Barclays Overweight $112 → $125
Jun-04-13Reiterated Deutsche Bank Hold $98 → $106
Mar-21-17 09:30AM  Zacks.com featured highlights: East West Bancorp, CBRE Group, Colliers International Group, C.R. Bard and Primerica
Mar-20-17 09:53AM  Bet on These 5 GARP Stocks for Solid Returns
Mar-16-17 12:14PM  C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : January 23rd, 2017 (record date) : By the numbers : March 16, 2017
Mar-13-17 11:48AM  New highs for the CNBC IQ 100
Mar-09-17 10:40AM  C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain
Mar-08-17 01:49PM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 8, 2017
Mar-07-17 10:30AM  Bard to Present at Barclays Global Healthcare Conference Business Wire
Mar-02-17 08:04AM  C.R. Bard (BCR) Up 8.2% Since Earnings Report: Can It Continue?
Feb-27-17 03:29PM  Go With the Upside on C.R. Bard
11:00AM  Bard to Present at Cowen and Company Healthcare Conference Business Wire
Feb-17-17 01:04PM  BARD C R INC /NJ/ Financials
Feb-13-17 05:16PM  BARD C R INC /NJ/ Files SEC form 10-K, Annual Report
Feb-03-17 09:30AM  The Zacks Analyst Blog Highlights: C. R. Bard, Illinois Tool Works, Sherwin-Williams, Cintas and S&P Global
Feb-02-17 12:27PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : February 2, 2017
Feb-01-17 07:21AM  C. R. Bard (BCR): Moving Average Crossover Alert
Jan-30-17 10:09AM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: 2016 By the Numbers : January 30, 2017
Jan-27-17 09:27AM  C.R. Bard (BCR) Q4 Earnings & Sales Better Than Expected +5.24%
Jan-26-17 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today
04:36PM  C.R. Bard tops Street 4Q forecasts
04:20PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:15PM  Bard Announces Fourth Quarter Results Business Wire
07:07AM  Q4 2016 C R Bard Inc Earnings Release - After Market Close
Jan-25-17 07:09AM  Medical Product Stocks' Earnings on Jan 26: ABMD, BCR, ABAX
Jan-23-17 08:53AM  C.R. Bard (BCR) to Report Q4 Earnings: A Surprise in Store?
Jan-19-17 02:25PM  C. R. Bard Stock Trades Ex-Dividend Thursday at Investopedia
Jan-05-17 07:04AM  C.R. Bard upgraded by Raymond James
Jan-04-17 10:30AM  Bard to Host Earnings Conference Call on January 26, 2017 Business Wire
07:35AM  BDs Latest Dividend Payment and Capital Allocation Strategy
Jan-03-17 01:42PM  C.R. Bard: High Growth, Low Risk? at Barrons.com
10:30AM  Bard to Present at J. P. Morgan Healthcare Conference Business Wire
Dec-23-16 09:21AM  What Do Analysts Recommend for Baxter International?
06:22AM  BARD C R INC /NJ/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Stat
Dec-14-16 04:15PM  Bard Declares Quarterly Dividend Business Wire
Dec-13-16 10:20AM  C.R. Bard, Inc. (New Jersey) Value Analysis (NYSE:BCR) : December 13, 2016
Dec-12-16 08:15AM  Analysts' Actions -- AIG, Fox, Lululemon, AT&T and More
07:25AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US : December 12, 2016
Dec-10-16 09:37PM  How C.R. Bard, Inc. (BCR) Stacks Up Against Twitter Inc (TWTR), Clorox and Other Peers at Insider Monkey
Dec-01-16 10:05AM  Baxter Makes Significant Advancements in Hemodialysis Treatments
Nov-30-16 10:30AM  Bard to Present at the Citi Healthcare Conference Business Wire
Nov-23-16 10:30AM  Bard to Present at the Piper Jaffray Healthcare Conference Business Wire
Nov-22-16 02:17PM  BARD C R INC /NJ/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance
Nov-17-16 08:11AM  CR Bard (BCR) Sees Hammer Chart Pattern: Time to Buy?
Nov-09-16 07:28AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US : November 9, 2016
Nov-08-16 10:30AM  Bard to Present at the Stifel Healthcare Conference Business Wire
Nov-02-16 06:02PM  DENTSPLY (XRAY) Q3 Earnings: Is Disappointment in Store?
08:05AM  Particle Therapy Business Witnessed Continued Growth Momentum in 4Q16
Nov-01-16 04:41PM  Dividend Aristocrats in Focus Part 25: CR Bard
Oct-28-16 02:50PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : October 28, 2016
Oct-26-16 01:12PM  BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report
11:45AM  C.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : October 24th, 2016 (record date) : By the numbers : October 26, 2016
10:21AM  C.R. Bard (BCR) Beats Q3 Earnings & Sales, FY16 View Up
09:42AM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q3, 2016 By the Numbers : October 26, 2016
04:05AM  Edited Transcript of BCR earnings conference call or presentation 25-Oct-16 9:00pm GMT
Oct-25-16 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today
04:33PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:32PM  C.R. Bard beats Street 3Q forecasts
04:15PM  Bard Announces Third Quarter Results Business Wire
07:07AM  Q3 2016 C R Bard Inc Earnings Release - After Market Close
Oct-24-16 04:19PM  C.R. Bard (BCR) to Report Q3 Earnings: What's in the Cards?
08:30AM  5 Stocks That Could Make Huge Earnings Moves This Week at Insider Monkey
Oct-21-16 09:01AM  BARD C R INC /NJ/ Files SEC form 8-K, Change in Directors or Principal Officers
Oct-19-16 08:22AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US : October 19, 2016
Oct-14-16 12:16PM  Private equity firms line up bids for BSN Medical - sources Reuters
11:29AM  German bandage BSN Medical seen attracting bids from peers, private equity - sources Reuters
10:22AM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : October 14, 2016
Oct-12-16 04:15PM  Bard Declares Quarterly Dividend Business Wire
Oct-05-16 08:32AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bearish Manner : BCR-US : October 5, 2016
Oct-03-16 10:30AM  Bard to Host Earnings Conference Call on October 25, 2016 Business Wire
Oct-01-16 01:17PM  Timothy Ring, CEO and Chairman of C.R. Bard Inc., Sold 92,293 Shares of the Company on Sept. 28
Sep-29-16 08:15PM  C.r. Bard Inc (BCR) Chairman and CEO Timothy M Ring Sold $21 million of Shares
Sep-27-16 08:15PM  C.r. Bard Inc (BCR) Chairman and CEO Timothy M Ring Sold $25.2 million of Shares
Sep-22-16 08:30AM  LUTONIX® Global Real-World Registry 24-Month Outcomes Presented at VIVA 2016 Business Wire
Sep-20-16 11:36AM  C.R. Bard, Inc. (New Jersey) Value Analysis (NYSE:BCR) : September 20, 2016
08:49AM  CR Bard (BCR) Gets FDA's IDE Approval for Lutonix DCB
Sep-19-16 05:37PM  FDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee Drug Coated Balloon Business Wire
08:13AM  C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US : September 19, 2016
Sep-09-16 10:26AM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : September 9, 2016
Sep-06-16 11:00AM  Bard to Present at Morgan Stanley Global Healthcare Conference Business Wire
Sep-01-16 08:04AM  A Look at How C.R. Bards Valuation Compares to Its Peers
Aug-31-16 04:04PM  Analyzing C.R. Bards Strong Product Pipeline
03:04PM  C.R. Bard Is Expected to Have a Strong Performance in 2016
12:34PM  Analysts Recommendations for C.R. Bard in 2016
Aug-29-16 11:04AM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : August 29, 2016
Aug-18-16 06:11PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : August 18, 2016
Aug-04-16 02:41PM  ETFs with exposure to C.R. Bard, Inc. (New Jersey) : August 4, 2016
Aug-03-16 01:17PM  C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016
Aug-02-16 04:59PM  Cardinal Health (CAH) Tops Q4 Earnings, '17 View Impressive
11:04AM  Analysts Recommendations for C.R. Bard after Its 2Q Earnings Post
09:05AM  Analyzing the Near-Term Product Pipeline of C.R. Bard
Aug-01-16 11:06AM  C.R. Bards New Treatments for Hernia Are Key Growth Drivers
09:08AM  C.R. Bards Buying Spree for Its Urology Segment Is Paying Off
Jul-29-16 11:17AM  C.R. Bards Vascular Segment Flowing Well despite Tougher Comps
11:17AM  C.R. Bard Registered Strong 2Q16 Performance, Beat Estimates
06:38AM  Did Baxter International Beat 2Q16 Earnings Estimates?
Jul-27-16 03:19PM  C.R. Bard (BCR) Beats Q2 Earnings & Sales, FY16 View Up
10:46AM  BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report
01:26AM  Edited Transcript of BCR earnings conference call or presentation 26-Jul-16 9:00pm GMT
Jul-26-16 05:00PM  C R Bard Inc Earnings Call scheduled for 5:00 pm ET today
04:37PM  C.R. Bard tops Street 2Q forecasts
04:24PM  BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal procedures; surgical slings and pelvic floor repair products; catheter stabilization devices; and products for therapeutic hypothermia. In addition, the company offers oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Further, it provides surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs; and hemostats and surgical sealants, as well as irrigation, wound drainage, and original equipment manufacturers' products. The company sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Beasley Jim CGroup PresidentFeb 21Option Exercise186.434,390818,40626,625Feb 22 03:37 PM
Beasley Jim CGroup PresidentFeb 21Sale245.004,3901,075,55022,235Feb 22 03:37 PM
WEILAND JOHN HVice Chairman, Pres. and COOFeb 14Sale240.4914,0913,388,80942,896Feb 15 04:58 PM
Groetelaars John PGroup PresidentFeb 14Sale240.49732176,04018,963Feb 15 04:58 PM
Collins Timothy PGroup PresidentFeb 14Sale240.503,768906,18626,646Feb 15 04:58 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 14Sale240.512,788670,55219,530Feb 15 04:58 PM
Beasley Jim CGroup PresidentFeb 14Sale240.523,213772,79622,235Feb 15 04:58 PM
Luboff Sharon MGroup Vice PresidentFeb 14Sale240.533,659880,09520,718Feb 15 04:58 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 14Sale240.53618148,64626,922Feb 15 04:58 PM
RING TIMOTHY MChairman and CEOFeb 14Sale240.5014,4253,469,16973,965Feb 15 04:58 PM
Luboff Sharon MGroup Vice PresidentFeb 13Option Exercise86.151,00086,14528,813Feb 14 03:21 PM
WEILAND JOHN HVice Chairman, Pres. and COOFeb 13Sale240.001,274305,75868,759Feb 14 03:20 PM
Collins Timothy PGroup PresidentFeb 13Sale240.30642154,27333,873Feb 14 03:20 PM
RING TIMOTHY MChairman and CEOFeb 13Sale240.021,767424,118102,139Feb 14 03:20 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 13Sale240.09642154,13628,140Feb 14 03:20 PM
Groetelaars John PGroup PresidentFeb 13Sale240.04450108,01820,362Feb 14 03:20 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 13Sale240.07469112,59424,662Feb 14 03:20 PM
Beasley Jim CGroup PresidentFeb 13Sale240.10734176,23027,652Feb 14 03:21 PM
Luboff Sharon MGroup Vice PresidentFeb 13Sale240.241,478355,08127,335Feb 14 03:21 PM
Larson Betty DVP - Human ResourcesFeb 10Sale240.923,292793,1108,399Feb 13 03:11 PM
Beasley Jim CGroup PresidentFeb 09Sale239.588,5932,058,67428,917Feb 10 06:23 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOFeb 09Sale239.577,5971,819,98029,405Feb 10 06:23 PM
RING TIMOTHY MChairman and CEOFeb 09Sale239.5620,3244,868,880105,618Feb 10 06:23 PM
Luboff Sharon MGroup Vice PresidentFeb 09Sale239.595,8011,389,87428,221Feb 10 06:23 PM
Collins Timothy PGroup PresidentFeb 09Sale238.987,6021,816,73835,138Feb 10 06:23 PM
DeFord John ASr. VP Sci Tech and Clin AfrsFeb 09Sale239.585,8161,393,38725,548Feb 10 06:23 PM
Groetelaars John PGroup PresidentFeb 09Sale239.665,5041,319,08621,248Feb 10 06:23 PM
Khichi Samrat S.Sr. VP, Gen Counsel & Secy.Feb 09Sale239.605,8271,396,12916,332Feb 10 06:23 PM
WEILAND JOHN HVice Chairman, Pres. and COOFeb 09Sale239.5414,2813,420,93271,131Feb 10 06:23 PM
Naughton Gail KDirectorJan 31Sale236.2236786,6941,620Feb 01 09:31 AM
Groetelaars John PGroup PresidentJan 11Sale235.00573134,65516,554Jan 12 12:05 PM
Lupisella Frank JrVice President and ControllerJan 10Sale232.002,735634,52011,603Jan 11 04:14 PM
Lupisella Frank JrVice President and ControllerJan 09Sale232.0021048,72014,338Jan 11 04:14 PM
Beasley Jim CGroup PresidentDec 30Option Exercise168.874,709795,18527,378Jan 03 02:52 PM
Lupisella Frank JrVice President and ControllerDec 30Sale226.0023753,56214,520Jan 03 02:52 PM
Beasley Jim CGroup PresidentDec 30Sale225.004,7091,059,52522,669Jan 03 02:52 PM
Luboff Sharon MGroup Vice PresidentDec 12Option Exercise86.156,000516,87029,837Dec 14 12:09 PM
WEILAND JOHN HVice Chairman, Pres. and COODec 12Option Exercise97.6911,1901,093,09572,780Dec 14 12:10 PM
Beasley Jim CGroup PresidentDec 12Option Exercise116.9711,9221,394,54434,591Dec 14 12:11 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 12Option Exercise131.7712,5911,659,05534,198Dec 13 06:51 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 12Sale218.8212,5912,755,13221,607Dec 13 06:51 PM
Beasley Jim CGroup PresidentDec 12Sale219.6411,9222,618,56322,669Dec 14 12:11 PM
WEILAND JOHN HVice Chairman, Pres. and COODec 12Sale219.6711,1902,458,05861,590Dec 14 12:10 PM
Luboff Sharon MGroup Vice PresidentDec 12Sale219.006,0001,314,00023,837Dec 14 12:09 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 09Option Exercise186.433,292613,71124,899Dec 13 06:51 PM
DeFord John ASr. VP Sci Tech and Clin AfrsDec 09Sale215.003,292707,78021,607Dec 13 06:51 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOOct 28Option Exercise95.993,971381,17629,689Oct 31 04:34 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOOct 28Sale211.125,7241,208,43323,965Oct 31 04:34 PM
RING TIMOTHY MChairman and CEOSep 28Option Exercise84.5837,2933,154,055133,323Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 28Sale227.3437,2938,478,14096,030Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 27Option Exercise84.7255,0004,659,717151,030Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 27Sale228.1355,00012,547,09996,030Sep 29 04:14 PM
RING TIMOTHY MChairman and CEOSep 26Option Exercise86.1555,0004,737,975151,030Sep 27 04:05 PM
RING TIMOTHY MChairman and CEOSep 26Sale227.9955,00012,539,47096,030Sep 27 04:05 PM
RING TIMOTHY MChairman and CEOSep 23Option Exercise86.1555,0004,737,975151,030Sep 27 04:05 PM
RING TIMOTHY MChairman and CEOSep 23Sale229.9255,00012,645,62496,030Sep 27 04:05 PM
Larson Betty DVP - Human ResourcesSep 19Option Exercise149.064,032601,01010,298Sep 20 03:24 PM
Larson Betty DVP - Human ResourcesSep 19Sale225.334,032908,5246,266Sep 20 03:24 PM
Khichi Samrat S.Sr. VP, Gen Counsel & Secy.Sep 06Option Exercise145.839,1831,339,15722,023Sep 08 09:43 AM
DeFord John ASr. VP Sci Tech and Clin AfrsSep 06Option Exercise151.817,9281,203,55029,535Sep 08 09:43 AM
DeFord John ASr. VP Sci Tech and Clin AfrsSep 06Sale221.067,9281,752,58421,607Sep 08 09:43 AM
Khichi Samrat S.Sr. VP, Gen Counsel & Secy.Sep 06Sale221.019,1832,029,52012,840Sep 08 09:43 AM
HOLLAND CHRISTOPHER SSenior Vice President and CFOMay 27Option Exercise95.993,970381,08031,306Jun 01 12:51 PM
HOLLAND CHRISTOPHER SSenior Vice President and CFOMay 27Sale219.893,970872,94527,336Jun 01 12:51 PM
Groetelaars John PGroup PresidentMay 17Sale219.881,162255,50517,431May 18 02:56 PM
Thompson Tommy GDirectorMay 12Option Exercise83.4750041,7377,036May 16 09:57 AM
Thompson Tommy GDirectorMay 12Sale219.52500109,7606,536May 16 09:57 AM
WHITE TONY LDirectorMay 05Option Exercise73.991,20088,78814,671May 09 11:50 AM
WHITE TONY LDirectorMay 05Sale216.191,200259,42313,471May 09 11:50 AM
Beasley Jim CGroup PresidentApr 28Option Exercise168.874,709795,18527,378May 02 09:46 AM
Beasley Jim CGroup PresidentApr 28Sale215.004,7091,012,43522,669May 02 09:46 AM
Luboff Sharon MGroup Vice PresidentApr 27Option Exercise86.1510,000861,45033,706Apr 29 10:14 AM
Luboff Sharon MGroup Vice PresidentApr 27Sale210.0010,0002,100,00023,706Apr 29 10:14 AM